Here, we propose SAGE-DM (Senescence-Associated Gluco-Endocrinopathy Diabetes Mellitus), a novel conceptual framework that extends the definition of so-called type 4 diabetes. SAGE-DM is characterised by insulin resistance and glucose dysregulation in lean or olders with sarcopenic obesity individuals, arising from endocrine senescence, chronic low-grade inflammation, and immunemetabolic crosstalk
It affects the process and elimination speed of the consumed alcohol
By reducing inflammation, BPC-157 peptide injections allow the body to heal faster and function better
BPC-157 is sold as a research compound and is not FDA-approved for human use
Neurological recovery: B12-dependent myelin sheath maintenance is relevant not only in neurological FIP presentations but in any cat whose systemic illness has produced peripheral neurological effects including the generalised weakness and proprioceptive deficits seen in severe wet FIP cases
Nonetheless, it is necessary to note that enthusiasm about the peptide is always tempered by science